Literature DB >> 20946997

Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study.

Raimund Erbel1, Stefan Möhlenkamp, Susanne Moebus, Axel Schmermund, Nils Lehmann, Andreas Stang, Nico Dragano, Dietrich Grönemeyer, Rainer Seibel, Hagen Kälsch, Martina Bröcker-Preuss, Klaus Mann, Johannes Siegrist, Karl-Heinz Jöckel.   

Abstract

OBJECTIVES: The purpose of this study was to determine net reclassification improvement (NRI) and improved risk prediction based on coronary artery calcification (CAC) scoring in comparison with traditional risk factors.
BACKGROUND: CAC as a sign of subclinical coronary atherosclerosis can noninvasively be detected by CT and has been suggested to predict coronary events.
METHODS: In 4,129 subjects from the HNR (Heinz Nixdorf Recall) study (age 45 to 75 years, 53% female) without overt coronary artery disease at baseline, traditional risk factors and CAC scores were measured. Their risk was categorized into low, intermediate, and high according to the Framingham Risk Score (FRS) and National Cholesterol Education Panel Adult Treatment Panel (ATP) III guidelines, and the reclassification rate based on CAC results was calculated.
RESULTS: After 5 years of follow-up, 93 coronary deaths and nonfatal myocardial infarctions occurred (cumulative risk 2.3%; 95% confidence interval: 1.8% to 2.8%). Reclassifying intermediate (defined as 10% to 20% and 6% to 20%) risk subjects with CAC <100 to the low-risk category and with CAC ≥400 to the high-risk category yielded an NRI of 21.7% (p = 0.0002) and 30.6% (p < 0.0001) for the FRS, respectively. Integrated discrimination improvement using FRS variables and CAC was 1.52% (p < 0.0001). Adding CAC scores to the FRS and National Cholesterol Education Panel ATP III categories improved the area under the curve from 0.681 to 0.749 (p < 0.003) and from 0.653 to 0.755 (p = 0.0001), respectively.
CONCLUSIONS: CAC scoring results in a high reclassification rate in the intermediate-risk cohort, demonstrating the benefit of imaging of subclinical coronary atherosclerosis. Our study supports its application, especially in carefully selected individuals with intermediate risk.
Copyright © 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20946997     DOI: 10.1016/j.jacc.2010.06.030

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  216 in total

Review 1.  Understanding the genetics of coronary artery disease through the lens of noninvasive imaging.

Authors:  Eunice Yang; Jose D Vargas; David A Bluemke
Journal:  Expert Rev Cardiovasc Ther       Date:  2012-01

2.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Elsayed Z Soliman; Paul D Sorlie; Nona Sotoodehnia; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2011-12-15       Impact factor: 29.690

3.  Comparison of dual-source and electron-beam CT for the assessment of coronary artery calcium scoring.

Authors:  N Reinsch; A A Mahabadi; N Lehmann; S Möhlenkamp; C Hoefs; B Sievers; T Budde; R Seibel; K-H Jöckel; R Erbel
Journal:  Br J Radiol       Date:  2011-10-18       Impact factor: 3.039

4.  Potential use of coronary artery calcium progression to guide the management of patients at risk for coronary artery disease events.

Authors:  John W McEvoy; Michael J Blaha; Khurram Nasir; Roger S Blumenthal; Steven R Jones
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-02

5.  Non-invasive imaging in assessment of the asymptomatic diabetic patient: Is it of value?

Authors:  Daniel S Berman; Matthew J Budoff; James K Min; Paolo Raggi; Alan Rozanski; Leslee Shaw; Prem Soman
Journal:  J Nucl Cardiol       Date:  2015-08-12       Impact factor: 5.952

Review 6.  Progression of coronary artery calcification by cardiac computed tomography.

Authors:  Amir A Mahabadi; N Lehmann; I Dykun; T Müller; H Kälsch; R Erbel
Journal:  Herz       Date:  2015-09       Impact factor: 1.443

7.  Relation of Diastolic Blood Pressure and Coronary Artery Calcium to Coronary Events and Outcomes (From the Multi-Ethnic Study of Atherosclerosis).

Authors:  Faisal Rahman; Mahmoud Al Rifai; Michael J Blaha; Khurram Nasir; Matthew J Budoff; Bruce M Psaty; Wendy S Post; Roger S Blumenthal; John W McEvoy
Journal:  Am J Cardiol       Date:  2017-08-08       Impact factor: 2.778

8.  Cross-sectional analysis of calcium intake for associations with vascular calcification and mortality in individuals with type 2 diabetes from the Diabetes Heart Study.

Authors:  Laura M Raffield; Subhashish Agarwal; Amanda J Cox; Fang-Chi Hsu; J Jeffrey Carr; Barry I Freedman; Jianzhao Xu; Donald W Bowden; Mara Z Vitolins
Journal:  Am J Clin Nutr       Date:  2014-08-06       Impact factor: 7.045

9.  Coronary artery calcium assessed with calibrated mass scoring in asymptomatic individuals: results from the Copenhagen General Population Study.

Authors:  Andreas D Knudsen; Andreas Fuchs; J Tobias Kühl; Ben A Arnold; Børge G Nordestgaard; Lars V Køber; Klaus F Kofoed
Journal:  Eur Radiol       Date:  2018-05-03       Impact factor: 5.315

Review 10.  Molecular imaging in cardiovascular disease: Which methods, which diseases?

Authors:  Jonathan R Lindner; Albert Sinusas
Journal:  J Nucl Cardiol       Date:  2013-12       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.